FibroBiologics, Inc.

FBLG

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001958777

SEC filings (opens in a new tab)

Insider trades, last 90 days

None

No open-market purchases or sales were filed in the last 90 days.

View insider trades

13F holders, Q2 2026

16

−1 vs. Q1 2026
Total value $269.61K

View 13F holders

Superinvestors holding FBLG

0

None of the superinvestors held FBLG at the end of Q2 2026.

See all holders

Price chart

Chart by TradingView (opens in a new tab)

Latest insider trades

Open-market purchases and sales by FBLG insiders, newest first.

Insider trades
Filed (ET)	Trade date	Insider	Transaction	Shares	Avg price	Value	Shares after	Holding change	Filing
Mar 5, 20268:00 AM ET	Mar 4, 2026	Khoja HamidChief Scientific Officer	PPurchaseCommon Stock	+30K	$0.38	+$11.4K	61.25K	+96.0%	SEC
Mar 4, 20265:50 PM ET	Mar 2 – Mar 4, 2026	O'HEERON PETECHIEF EXECUTIVE OFFICER	PPurchaseCommon Stock	+51.5K	$0.3792	+$19.53K	5.96M	+0.9%	SEC
Mar 3, 20268:00 AM ET	Mar 2, 2026	Davis JasonChief Financial Officer	PPurchaseCommon Stock	+70K	$0.4139	+$28.97K	70K	New position	SEC
Mar 2, 20269:15 AM ET	Feb 27, 2026	GARCIA RUBEN AGeneral Counsel	PPurchaseCommon Stock	+40K	$0.3264	+$13.06K	180K	+28.6%	SEC
Dec 12, 20257:16 AM ET	Dec 11, 2025	GARCIA RUBEN AGeneral Counsel	PPurchaseCommon Stock	+140K	$0.34	+$47.6K	140K	New position	SEC

Top 5 13F holders, Q2 2026

The largest institutional positions in FBLG at the end of Q2 2026.

Institutions holding FBLG in Q2 2026
Institution	Shares	Value	% of portfolio	Change in shares	Action
Cascade Financial Partners, LLC	108,828	$103.14K	0.01%	+92,400+562.5%	Added
Fund Evaluation Group, LLC	51,794	$49.09K	0.00%	00.0%	Unchanged
GEODE CAPITAL MANAGEMENT, LLC	30,299	$28.72K	0.00%	+690+2.3%	Added
VANGUARD CAPITAL MANAGEMENT LLC	27,769	$26.33K	0.00%	−39,896−59.0%	Reduced
Qube Research & Technologies Ltd	24,313	$23.04K	0.00%	+24,313	New